Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 6

Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature

Authors Daniel J Abrams, Donald C Rojas, David B Arciniegas

Published 5 December 2008 Volume 2008:4(6) Pages 1089—1109


Review by Single-blind

Peer reviewer comments 2

Daniel J Abrams1, Donald C Rojas1, David B Arciniegas1,2

1Department of Psychiatry; 2Neurobehavioral Disorders Program, Departments of Psychiatry and Neurology, University of Colorado School of Medicine, Denver, CO, USA

Abstract: Considerable debate surrounds the inclusion of schizoaffective disorder in psychiatric nosology. Schizoaffective disorder may be a variant of schizophrenia in which mood symptoms are unusually prominent but not unusual in type. This condition may instead reflect a severe form of either major depressive or bipolar disorder in which episode-related psychotic symptoms fail to remit completely between mood episodes. Alternatively, schizoaffective disorder may reflect the co-occurrence of two relatively common psychiatric illnesses, schizophrenia and a mood disorder (major depressive or bipolar disorder). Each of these formulations of schizoaffective disorder presents nosological challenges because the signs and symptoms of this condition cross conventional categorical diagnostic boundaries between psychotic disorders and mood disorders. The study, evaluation, and treatment of persons presently diagnosed with schizoaffective may be more usefully informed by a dimensional approach. It is in this context that this article reviews and contrasts the categorical and dimensional approaches to its description, neurobiology, and treatment. Based on this review, an argument for the study and treatment of this condition using a dimensional approach is offered.

Keywords: schizoaffective disorder, schizophrenia, bipolar disorder, manic-depressive disorder

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD

Holz O, Roepcke S, Watz H, Tegtbur U, Lahu G, Hohlfeld JM

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1393-1402

Published Date: 21 July 2015

Age-associated decrease in global DNA methylation in patients with major depression

Tseng PT, Lin PY, Lee Y, Hung CF, Lung FW, Chen CS, Chong MY

Neuropsychiatric Disease and Treatment 2014, 10:2105-2114

Published Date: 10 November 2014

Risk factors for choroidal detachment after trabeculectomy with mitomycin C

Haga A, Inatani M, Shobayashi K, Kojima S, Inoue T, Tanihara H

Clinical Ophthalmology 2013, 7:1417-1421

Published Date: 11 July 2013

Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients.

Francis Lavergne, Ivan Berlin, Alex Gamma, Hans Stassen, Jules Angst

Neuropsychiatric Disease and Treatment 2005, 1:59-68

Published Date: 15 April 2005